je.st
news
pSivida Corp. (PSDV) Upgraded to "Hold" at Zacks Investment Research
2016-01-02 14:07:55| Biotech - Topix.net
According to Zacks, "pSivida Corp., a specialty pharmaceutical company, combines existing drugs with its sustained release delivery technologies to develop transformational products primarily in ophthalmology. pSivida's two proprietary technology systems are Durasert and Tethadur.
Tags: research
hold
investment
corp
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||